Ranbaxy Blocked From Copying Schering's Clarinex
Schering-Plough Corp. has won a boost in its battle to protect Clarinex, with a federal judge issuing a permanent injunction barring Indian generic drug maker Ranbaxy Laboratories Ltd. from manufacturing or...To view the full article, register now.
Already a subscriber? Click here to view full article